Thus, it was inferred from above data that CAH (+) treatment might promote the proliferation of CD4+CD8+ double positive T subsets and boost a systemic and durable immune defense against metastatic melanoma. The gene discussed is CD8A; the disease is congenital adrenal hyperplasia.